Eylea (Macular Edema and Macular Degeneration) Forecast and Market Analysis to 2023 By RnRMarketResearch
Browse more reports on Pharmaceuticals at http://www.rnrmarketresearch.com/reports/lifesciences/pharmaceuticals Š http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Eylea (Macular Edema and Macular Degeneration) Forecast and Market Analysis to 2023 RnRMarketResearch.com adds “Eylea (Macular Edema and Macular Degeneration) – Forecast and Market Analysis to 2023”to its store. Eylea (aflibercept) is a recombinant fusion protein co-developed by Regeneron and Bayer AG. Eylea acts as a VEGF inhibitor and is approved for the treatment of wAMD and ME-CRVO in all 7MM, and for DME in the US and EU. The developers are also attempting to gain approval for Eylea for DME in Japan, and for ME-BRVO throughout in the EU and Japan. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. © http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Eylea (Macular Edema and Macular Degeneration) Forecast and Market Analysis to 2023 Macular Edema is a condition where fluid accumulates on the macula, leading to vision impairment or in severe cases even vision loss. The three main types of ME are diabetic macular edema (DME), and macular edema following either a central or branch retinal vein occlusion (ME-CRVO and ME-BRVO). Agerelated macular degeneration (AMD) is a painless eye condition which leads to gradual, irreversible, loss of central vision, and is one of the leading causes of blindness among people aged 50 and over in the developed world. Currently the ME and AMD markets are dominated by the use of anti-VEGF monotherapy, however, in recent years, corticosteroid implants have been reaching the ME market which could challenge the stronghold these drugs have in this sector. Complete Report is available at http://www.rnrmarketresearch.com/eyleamacular-edema-and-macular-degeneration-forecast-and-market-analysis-to2023-market-report.html .
Š http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Eylea (Macular Edema and Macular Degeneration) Forecast and Market Analysis to 2023 Scope: • Overview of Macular Edema and Macular Degeneration, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape. • Detailed information on Eylea including product description, safety and efficacy profiles as well as a SWOT analysis. • Sales forecast for Eylea for the top seven countries from 2013 to 2023. • Sales information covered for the US, France, Germany, Italy, Spain, the UK and Japan.
© http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Eylea (Macular Edema and Macular Degeneration) Forecast and Market Analysis to 2023 Reasons to Buy:
• Understand and capitalize by identifying products that are most likely to ensure a robust return. • Stay ahead of the competition by understanding the changing competitive landscape for Macular Edema and Macular Degeneration. • Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential. • Make more informed business decisions from insightful and indepth analysis of Eylea performance. • Obtain sales forecast for Eylea from 2013-2023 in top seven countries (the US, France, Germany, Italy, Spain, the UK and Japan). © http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Eylea (Macular Edema and Macular Degeneration) Forecast and Market Analysis to 2023 Table of Contents: 1 Table of Contents 6 1.1 List of Tables 8 1.2 List of Figures 9 2 Introduction 10 2.1 Related Reports 11 3 Disease Overview 13 3.1 Macular Degeneration Overview 13 3.1.1 Etiology and Pathophysiology 15 3.1.2 Classification 19 3.1.3 Symptoms and Diagnosis 21 3.2 Macular Edema Overview 24
Š http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Eylea (Macular Edema and Macular Degeneration) Forecast and Market Analysis to 2023 For more details contact Mr. Ritesh Tiwari : sales@rnrmarketresearch.com / +18883915441
RnRMarkertResearch RnRMarketResearch.com, an online repository of market research reports, offers in-depth analysis of over 5000 market segments. RnR Market Research library has syndicated reports by leading market research publishers across the globe.
Š http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441